jacky
06-20-2009, 11:27 AM
this plant t. undulata, otherwise known as Becchete to the Matses/Matis tribe, a hunting medicinal that is used directly in the eye.
apparently this plants main alkaloid is ibogaine...
this is very interesting, and is a recent ethnobotanical discovery.
perhaps its just another tabernaemontana species that contains ibogaine...but not in amounts that would allow it to be used out of traditional context, as an alternate uncontrolled iboga substitute.
this type of clumsy associating of different plant medicinals is common in forums like this....people get excited, without considering that expecting two different plants to have the same potential is asking alot of nature.
still, its an obvious thought probably to many that follow this type of subject.
depending on potency, this plant could be interesting, even if it contains only a fraction of the percentage of ibogaine that tabernanthe iboga does.
the plant is legal for trade as far as I know, unless it is endangered..
and there are rumors that it will be hitting the global market as a research botanical in the coming months.
apparently this plants main alkaloid is ibogaine...
this is very interesting, and is a recent ethnobotanical discovery.
perhaps its just another tabernaemontana species that contains ibogaine...but not in amounts that would allow it to be used out of traditional context, as an alternate uncontrolled iboga substitute.
this type of clumsy associating of different plant medicinals is common in forums like this....people get excited, without considering that expecting two different plants to have the same potential is asking alot of nature.
still, its an obvious thought probably to many that follow this type of subject.
depending on potency, this plant could be interesting, even if it contains only a fraction of the percentage of ibogaine that tabernanthe iboga does.
the plant is legal for trade as far as I know, unless it is endangered..
and there are rumors that it will be hitting the global market as a research botanical in the coming months.